{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:42:54Z","timestamp":1781066574848,"version":"3.54.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ejphar.2015.05.051","type":"journal-article","created":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T09:07:31Z","timestamp":1432890451000},"page":"229-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["KBP-042 improves bodyweight and glucose homeostasis with indices of increased insulin sensitivity irrespective of route of administration"],"prefix":"10.1016","volume":"762","author":[{"given":"Sara T.","family":"Hjuler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim V.","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Gydesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten A.","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2015.05.051_bib1","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.2337\/db12-0976","article-title":"Link between GIP and osteopontin in adipose tissue and insulin resistance","volume":"62","author":"Ahlqvist","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2015.05.051_bib2","article-title":"A novel oral dual amylin and calcitonin receptor agonist (KBP-042) exerts anti-obesity and anti-diabetic effects in rats","author":"Andreassen","year":"2014","journal-title":"Am. J. Physiol.: Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2015.05.051_bib3","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2337\/diab.45.5.633","article-title":"Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM","volume":"45","author":"Carey","year":"1996","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.ejphar.2015.05.051_bib4","first-page":"E908","article-title":"Disruption of GIP\/GIPR axis in human adipose tissue is linked to obesity and insulin resistance","volume":"99","author":"Ceperuelo-Mallafre","year":"2014","journal-title":"J. Clin. Endocrinol. Metab 2014 May"},{"key":"10.1016\/j.ejphar.2015.05.051_bib5","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/oby.2007.626","article-title":"Low-dose pramlintide reduced food intake and meal duration in healthy, normal-weight subjects","volume":"15","author":"Chapman","year":"2007","journal-title":"Obesity"},{"key":"10.1016\/j.ejphar.2015.05.051_bib6","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2337\/diabetes.51.4.1005","article-title":"The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments","volume":"51","author":"Cnop","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2015.05.051_bib7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2165\/0063030-200822060-00004","article-title":"Pramlintide in the treatment of diabetes mellitus","volume":"22","author":"Edelman","year":"2008","journal-title":"BioDrugs"},{"key":"10.1016\/j.ejphar.2015.05.051_bib8","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/GME.0b013e31827c58ab","article-title":"Oral salmon calcitonin protects against impaired fasting glycemia, glucose intolerance, and obesity induced by high-fat diet and ovariectomy in rats","volume":"20","author":"Feigh","year":"2013","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.ejphar.2015.05.051_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1476-5381.2012.01979.x","article-title":"Oral salmon calcitonin attenuates hyperglycaemia and preserves pancreatic beta-cell area and function in Zucker diabetic fatty rats","volume":"167","author":"Feigh","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.ejphar.2015.05.051_bib10","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1463-1326.2011.01425.x","article-title":"A novel oral form of salmon calcitonin improves glucose homeostasis and reduces body weight in diet-induced obese rats","volume":"13","author":"Feigh","year":"2011","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ejphar.2015.05.051_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejphar.2014.05.016","article-title":"Oral salmon calcitonin enhances insulin action and glucose metabolism in diet-induced obese streptozotocin-diabetic rats","volume":"737C","author":"Feigh","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejphar.2015.05.051_bib12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1055\/s-0031-1298027","article-title":"Oral Salmon Calcitonin Improves Fasting and Postprandial Glycemic Control in Lean Healthy Rats","volume":"44","author":"Feigh","year":"2012","journal-title":"Horm. Metab Res."},{"key":"10.1016\/j.ejphar.2015.05.051_bib13","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0016-5085(95)90382-8","article-title":"Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus","volume":"109","author":"Frank","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2015.05.051_bib14","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/27376","article-title":"Leptin and the regulation of body weight in mammals","volume":"395","author":"Friedman","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2015.05.051_bib15","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1007\/s00125-007-0710-4","article-title":"Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets","volume":"50","author":"Gault","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2015.05.051_bib16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/1056-8719(94)90079-5","article-title":"The measurement of gastric emptying in conscious rats by monitoring serial changes in serum acetaminophen level","volume":"31","author":"Hatanaka","year":"1994","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2015.05.051_bib17","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/j.1464-5491.2008.02579.x","article-title":"Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes","volume":"25","author":"Hojberg","year":"2008","journal-title":"Diabet. Med."},{"key":"10.1016\/j.ejphar.2015.05.051_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1758-5996-6-49","article-title":"The relationship between regional abdominal fat distribution and both insulin resistance and subclinical chronic inflammation in non-diabetic adults","volume":"6","author":"Hsieh","year":"2014","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.ejphar.2015.05.051_bib19","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1007\/s00125-009-1422-8","article-title":"Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications","volume":"52","author":"Irwin","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2015.05.051_bib20","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes","volume":"444","author":"Kahn","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2015.05.051_bib21","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/0091270010372625","article-title":"Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trials","volume":"51","author":"Karsdal","year":"2011","journal-title":"J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejphar.2015.05.051_bib22","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/bcp.12557","article-title":"Lessons learned from the clinical development of oral peptides","volume":"79","author":"Karsdal","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejphar.2015.05.051_bib23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/jne.12131","article-title":"High fat diet induces leptin resistance","volume":"26","author":"Koch","year":"2014","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.ejphar.2015.05.051_bib24","first-page":"E924","article-title":"Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice","volume":"302","author":"Kusakabe","year":"2012","journal-title":"Am. J. Physiol.: Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2015.05.051_bib25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0196-9781(99)00208-9","article-title":"Amylin receptors mediate the anorectic action of salmon calcitonin (sCT)","volume":"21","author":"Lutz","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2015.05.051_bib26","first-page":"R1855","article-title":"Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight","volume":"293","author":"Mack","year":"2007","journal-title":"Am. J. Physiol.: Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2015.05.051_bib27","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1463-1326.2011.01465.x","article-title":"Glucoregulatory effects and prolonged duration of action of davalintide: a novel amylinomimetic peptide","volume":"13","author":"Mack","year":"2011","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ejphar.2015.05.051_bib28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ijo.2009.238","article-title":"Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight","volume":"34","author":"Mack","year":"2010","journal-title":"Int. J. Obes."},{"issue":"4","key":"10.1016\/j.ejphar.2015.05.051_bib29","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1017\/S1092852913000667","article-title":"Metabolic syndrome and major depression","volume":"19","author":"Marazziti","year":"2014","journal-title":"CNS Spectr."},{"key":"10.1016\/j.ejphar.2015.05.051_bib30","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2015.05.051_bib31","first-page":"E1746","article-title":"GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet","volume":"293","author":"McClean","year":"2007","journal-title":"Am. J. Physiol.: Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2015.05.051_bib32","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nm727","article-title":"Inhibition of gastric inhibitory polypeptide signaling prevents obesity","volume":"8","author":"Miyawaki","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2015.05.051_bib33","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.peptides.2008.02.002","article-title":"Central and peripheral administration of amylin induces energy expenditure in anesthetized rats","volume":"29","author":"Osaka","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2015.05.051_bib34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4239\/wjd.v4.i3.47","article-title":"Bariatric surgery-mediated weight loss and its metabolic consequences for type-2 diabetes","volume":"4","author":"Raghow","year":"2013","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.ejphar.2015.05.051_bib35","first-page":"R605","article-title":"Comparative effects of amylin and cholecystokinin on food intake and gastric emptying in rats","volume":"280","author":"Reidelberger","year":"2001","journal-title":"Am. J. Physiol.: Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2015.05.051_bib36","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.2337\/dc07-0589","article-title":"Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes using basal insulin","volume":"30","author":"Riddle","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2015.05.051_bib37","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.1210\/en.2006-0393","article-title":"Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression","volume":"147","author":"Roth","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2015.05.051_bib38","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.clinthera.2005.10.009","article-title":"Pramlintide in the treatment of type 1 and type 2 diabetes mellitus","volume":"27","author":"Ryan","year":"2005","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejphar.2015.05.051_bib39","first-page":"G946","article-title":"Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition","volume":"278","author":"Samsom","year":"2000","journal-title":"Am. J. Physiol.: Gastrointest. Liver Physiol."},{"issue":"Suppl. 3","key":"10.1016\/j.ejphar.2015.05.051_bib40","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.2337\/diabetes.53.suppl_3.S233","article-title":"Amylin agonists: a novel approach in the treatment of diabetes","volume":"53","author":"Schmitz","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2015.05.051_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0022-3565(24)39040-8","article-title":"Amylin receptor phenotypes derived from human calcitonin receptor\/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment","volume":"294","author":"Tilakaratne","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2015.05.051_bib42","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1210\/en.2008-0770","article-title":"Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms","volume":"149","author":"Trevaskis","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2015.05.051_bib43","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1210\/en.2010-0590","article-title":"Enhanced amylin-mediated body weight loss in estradiol-deficient diet-induced obese rats","volume":"151","author":"Trevaskis","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2015.05.051_bib44","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1152\/physrev.00042.2009","article-title":"Islet amyloid polypeptide, islet amyloid, and diabetes mellitus","volume":"91","author":"Westermark","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2015.05.051_bib45","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.physbeh.2007.02.012","article-title":"The acute effect of amylin and salmon calcitonin on energy expenditure","volume":"91","author":"Wielinga","year":"2007","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2015.05.051_bib46","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1054-3589(05)52006-4","article-title":"Inhibition of gastric emptying","volume":"52","author":"Young","year":"2005","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.05.051_bib47","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1054-3589(05)52008-8","article-title":"Inhibition of glucagon secretion","volume":"52","author":"Young","year":"2005","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.05.051_bib48","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bbrc.2005.07.164","article-title":"Gastric inhibitory polypeptide modulates adiposity and fat oxidation under diminished insulin action","volume":"335","author":"Zhou","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915300492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915300492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T04:31:15Z","timestamp":1748406675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299915300492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":48,"alternative-id":["S0014299915300492"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.05.051","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KBP-042 improves bodyweight and glucose homeostasis with indices of increased insulin sensitivity irrespective of route of administration","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.05.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}